Medicus Pharma LTD Schedule 13G passive stakes

Ajay Raju and associated entities report a combined 3.7% beneficial ownership in Medicus Pharma Ltd. common shares.

Dr. Raza Bokhari and RBx Capital, LP have disclosed a combined beneficial ownership of 4.8% of Medicus Pharma Ltd.'s common shares.

Armistice Capital, LLC and Steven Boyd have disclosed a passive 4.99% beneficial ownership stake in Medicus Pharma Ltd., totaling 935,724 common shares as of June 30, 2025.

Dr. Kenneth Melani and Velocity Fund Partners, LP report beneficial ownership of Medicus Pharma shares exceeding 15%.

John Hathaway and SkinJect Partners LLC report a 4.5% passive ownership stake in Medicus Pharma Ltd. through a Schedule 13G amendment.

Investment firm Armistice Capital, LLC and its managing member Steven Boyd have disclosed a passive beneficial ownership of 9.43% in Medicus Pharma Ltd., totaling 1,266,000 common shares.

Dr. Kenneth Melani and Velocity Fund Partners, LP have jointly disclosed beneficial ownership of 28.1% of Medicus Pharma Ltd.'s common shares as of December 31, 2024.

Dr. Raza Bokhari and RBx Capital, LP have reported beneficial ownership of 8.9% and 6.7% respectively, of Medicus Pharma Ltd.'s common shares as of December 31, 2024.

John Hathaway and SkinJect Partners LLC have disclosed a passive beneficial ownership of 6.8% of Medicus Pharma Ltd.'s common shares, totaling 800,952 shares, as of December 31, 2024.

Ajay Raju, 215 Capital Togo PHL Fund I, LP, and Togo PHL Management LLC have jointly disclosed a beneficial ownership of 16.9% in Medicus Pharma Ltd.'s common shares.